Laekna, Inc. (HKG:2105)
Hong Kong · Delayed Price · Currency is HKD 7.55
-0.60 (-7.36%)
Jun 18, 2026, 2:03 PM HKT
Laekna Market Cap
Laekna has a market cap or net worth of 3.45 billion as of June 17, 2026. Its market cap has decreased by -48.14% in one year.
Market Cap
3.45B
Enterprise Value
2.18B
Revenue
118.76M
Ranking
n/a
PE Ratio
n/a
Stock Price
7.55
Market Cap Chart
Since June 29, 2023, Laekna's market cap has decreased from 5.85B to 3.45B, a decrease of -41.03%. That is a compound annual growth rate of -16.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 17, 2026 | 3.45B | -39.20% |
| Dec 31, 2025 | 5.68B | 62.12% |
| Dec 31, 2024 | 3.50B | -54.90% |
| Dec 29, 2023 | 7.76B | 32.67% |
| Jun 29, 2023 | 5.85B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ocumension Therapeutics | 4.26B |
| Guangzhou Innogen Pharmaceutical Group | 3.69B |
| Mirxes Holding Company | 3.66B |
| Jacobio Pharmaceuticals Group | 3.47B |
| Medtide | 3.45B |
| Qyuns Therapeutics | 3.41B |
| Jiangsu Recbio Technology | 2.97B |
| Shandong Boan Biotechnology | 2.91B |